Decrease in immune activation in HIV-infected patients treated with highly active antiretroviral therapy correlates with the function of hematopoietic progenitor cells and the number of naive CD4+ cells

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 6, 2000, Pages 597-603

  Nielsen, S D ^a   Sorensen T U ^a   Ersboll A K ^a   Ngo, N ^a   Mathiesen, L ^a   Nielsen, J O ^a   Hansen, J E S ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EDETIC ACID; GAMMA INTERFERON; HEPARIN; INDINAVIR; INTERLEUKIN 2; INTERLEUKIN 4; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL CLONING; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CLONOGENIC ASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; MALE; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ANTI-HIV AGENTS; ANTIGENS, CD4; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HUMANS; MALE; TIME FACTORS; VIRAL LOAD;

EID: 17744390548     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655400459487     Document Type: Article

References (42)

1. + T cell homeostasis and function in advanced HIV disease
2. Highly active antiretroviral therapy during early HIV infection reverses T cell activation and maturation abnormalities
3. Immunological effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection
4. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
5. Viral dynamics in human immunodeficiency virus type 1 infection
6. HIV does not replicate in naive CD4 cells stimulated with CD3/CD28
7. Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects
8. T cell progenitor function during progressive HIV-1 infection and after antiretroviral therapy
9. + progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis
10. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors
11. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients
12. The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication
13. +) cells in AIDS patients
14. + T cell repertoire that are not immediately restored by antiviral or immune-based therapies
15. + T cell population with memory rather than naive cells
16. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
17. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 lymphocytes in asymptomatic HIV infection: Changes in the expression of CD45RO, CD45RA; CD11b, CD38, HLA-DR, and CD25 antigens
18. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1
19. + lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy
20. + T cell levels: Results of 6 years of follow-up
21. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage
22. + T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up
23. + cell count, soluble immune combinations of HLA-DR and CD38 expression
24. + T cell correlate with plasma human immunodeficiency virus (HIV-1) RNA levels in HIV-1 infection
25. Three-color cytoflourometric analysis of CD8 cell subsets in HIV-1 infection
26. Programmed cell death in peripheral lymphocytes from HIV-infected persons
27. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocytes apoptosis
28. Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load
29. Programmed death of T cells in HIV-1 infection
30. Expression of the activation antigens CD69 reflects post-expansion functionality of PBMC from healthy donors and HIV-infected patients
31. A Th1 to Th2 switch is a critical step in the etiology of HIV infection
32. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals
33. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry
34. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals
35. H2 predominance in HIV-infected individuals
36. h0 cells
37. + T cell subset
38. Analysis of repeated measurements
39. + lymphocyte counts and the risk of progression to AIDS
40. + cells in late stages of HIV infection is related to increased risk of death: Evidence from a cohort of 347 HIV-infected individuals
41. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection
42. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy